Mesoblast (MESO) Cash & Equivalents (QoQ) (2016 - 2023)
Mesoblast (MESO) Cash & Equivalents (QoQ) (2016 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
46.15% |
| Mar 31, 2023 |
-27.83% |
| Dec 31, 2022 |
-20.92% |
| Sep 30, 2022 |
41.45% |
| Jun 30, 2022 |
-21.25% |
| Mar 31, 2022 |
-19.07% |
| Dec 31, 2021 |
-18.20% |
| Sep 30, 2021 |
-15.29% |
| Jun 30, 2021 |
-13.51% |
| Mar 31, 2021 |
22.37% |
| Dec 31, 2020 |
19.61% |
| Sep 30, 2020 |
-16.40% |
| Jun 30, 2020 |
115.27% |
| Mar 31, 2020 |
-26.15% |
| Dec 31, 2019 |
135.55% |
| Sep 30, 2019 |
-31.51% |
| Jun 30, 2019 |
-28.36% |
| Mar 31, 2019 |
-8.62% |
| Dec 31, 2018 |
39.68% |
| Sep 30, 2018 |
46.02% |
